Safety Alerts & Recalls

What does this mean?

This recall for Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation from AstraZeneca Pharmaceuticals LP was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation and are concerned, you should speak to your doctor or pharmacist.

AstraZeneca Pharmaceuticals LP Recalls Select Lots of Tudorza Pressair, 400 mcg per actuation

AstraZeneca Pharmaceuticals LP is recalling select lots of Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation. The following lot numbers are being recalled because the inhaler counter in these lots may be set to a number other than 60: Lot # 1144394, Expiry: 04/2018; Lot # 1145539, Expiry: 04/2018; Lot # 1145868, Expiry: 05/2018

Tudorza Pressair contains the active ingredient aclindinium bromide and is commonly used in the treatment of COPD. This recall alert only applies to the select lots of Tudorza Pressair, 400 mcg per actuation. No other Tudorza products were involved in this recall.

To search for and view the FDA notice about this recall, please visit: more information here

Source: FDA
Publication Date: 2016-07-06
Last Updated: 2016-07-06

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.